| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| The ab initio calculations at the longer RO . . . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Since chaperone molecules such as calreticulin ( Crt ) have been shown to be important in the maturation of many glycoproteins , we investigated the interaction between Crt and APP . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Calreticulin ( CRT ) was identified as a frequent target of serum autoantibodies ( Ab ) in various diseases , but anti CRT Ab of IgA isotype were described only in coeliac ( CLD ) and some hepatic diseases . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Because intracellular inclusions , containing either amyloid beta ( Abeta ) or phosphorylated tau , are the characteristic feature of sporadic inclusion body myositis ( s IBM ) muscle biopsies , we studied expression and immunolocalization of five ER chaperones , calnexin , calreticulin , GRP 94 , BiP / GRP78 , and ERp 72 , in s IBM and control muscle biopsies . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Based on immunoblotting studies of cerebrospinal fluid ( CSF ) from normals , we find that the bulk of the abetas are bound to the ER chaperones , ERp 57 and calreticulin , suggesting that these may be carrier proteins which prevent aggregation of the abetas and that the deposits are due to faulty ER posttranslational processing of APP with the failure to form this complex . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| F ( ab ' ) 2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| The observed C1q induced potentiation of platelet aggregation in response to agg IgG was blocked by polyclonal antibody F ( ab ' ) 2 directed against platelet binding sites recognizing the collagen like domain of C1q ( cC1qR ) or by mAb Fab ( IV . 3 ) directed against platelet FcgammaRII receptors . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| F ( ab ' ) 2 fragments of IgG were observed to inhibit specific Ro binding by either human or antigen induced rabbit sera , while Fc fragments of IgG failed to inhibit Ro binding . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Here we illustrate advantages and pitfalls of MRS using studies of two fluorine containing cancer drugs : a beta , beta difluoro analogue of the alkylating agent chlorambucil and a fluorinated derivative of the nitroimidazole misonidazole , Ro 07 0741 . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| As previously reported , 125I APP bound to cerebellar membranes with a Kd of 0 . 365 nM and an Ro of 323 fmol / mg , and unlabeled NPY showed about one order of magnitude lower affinity than did unlabeled APP for 125I APP binding sites . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Further saturation of the [ 125I ] PIN binding sites in cerebral cortex showed that the inhibition by Ro 3 7894 was competitive but with a high and low affinity component , consistent with Ro 3 7894 being a beta 1 selective competitive antagonist . ^^^ Ro 3 7894 is a beta 1 selective competitive antagonist with no apparent irreversible effects . ( ABSTRACT TRUNCATED AT 400 WORDS ) . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| The effects of several cardiotonic agents ( ARL 115 , Amrinone , RMI 82 249 , Milrinone , CI 914 , RO 13 6438 and APP 201 533 ) were compared with those of ouabain on pig isolated coronary artery , guinea pig isolated atria and guinea pig perfused heart to compare vasodilatory and inotropic responses . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Immunization with Ro 52 resulted in rapid , high titer Ab production to Ro 52 , followed 7 to 14 days later by lower titer autoantibody production to Ro 60 . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Tazobactam , tested as control , had opposite behaviour to Ro 48 1256 , potentiating beta lactams when resistance was due to Class A beta lactamases but failing to reverse resistance mediated by AmpC . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Anti La and Ro ( SS A ) Ab responses were monitored following immunization of healthy mice with defined immunodominant and subdominant T cell determinants of the La ( SS B ) autoantigen synthesized as either monomeric or multiple antigenic ( MAP ) peptides . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| One compound , Ro 90 7501 , was found to efficiently retard mature fibril formation , while extended polymeric Abeta 42 sheets and fibrillar intermediates are accumulated . ^^^ Ro 90 7501 may serve as a prototypic inhibitor for Abeta 42 fibril formation and as a tool for studying the molecular mechanism of fibril assembly . . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Patients with anemia or photosensitivity had higher titers of anti Ro antibody ( Ab ) than those without the respective clinical findings ( p = 0 . 001 and 0 . 002 , respectively ) . ^^^ However , patients with proteinuria had lower anti Ro Ab titers ( p < 0 . 05 ) . ^^^ However , patients with proteinuria had significantly lower titers of anti Ro Ab than those without proteinuria . . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Hydrolyses of phosphorus halides , ( RO ) ( 2 ) POX where R = H or Me and 10 = F or Cl , in the gas phase and in the reaction field have been investigated theoretically with ab initio and the density functional theory ( DFT ) . ^^^ |
|
| Interacting proteins: P27797 and P05067 |
Pubmed |
SVM Score :0.0 |
| Positive normal serum bound Ro / SSA in Western immunoblots and binding activity was demonstrated in the F ( ab ' ) 2 fragment of IgG . ^^^ |
|